Emanate Wireless, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Emanate Wireless, Inc. - overview
Established
2014
Location
-, OH, US
Primary Industry
Medical Devices & Equipment
About
Emanate Wireless, Inc. specializes in advanced wireless monitoring solutions for healthcare environments, focusing on real-time location systems and intelligent asset monitoring to enhance operational efficiency. Founded in 2014 and headquartered in Hudson, US, Emanate Wireless, Inc. develops innovative wireless solutions for healthcare.
The company has raised USD 1. 5 mn in ANGEL funding as of December 2016. Gary Sugar is the founder, and Neil Diener is the current CEO. Emanate Wireless specializes in advanced wireless monitoring solutions, primarily through its innovative product offerings such as RadioVision™, PowerPath™ Temp, and UCLS.
RadioVision™ is a BLE (Bluetooth Low Energy) real-time location system (RTLS) that achieves clinical-grade accuracy with a 99. 9% room-level detection capability, facilitating entry and exit tracking in healthcare environments. The PowerPath™ Temp is a smart cold-storage monitor designed to track internal temperatures and conditions of temperature-sensitive products, ensuring compliance and preventing loss of inventory. UCLS, the next-generation AI-based clinical asset monitoring solution, enhances the management of clinical assets through intelligent insights.
These products primarily serve healthcare facilities, pharmaceutical companies, and laboratories across North America and Europe, addressing critical challenges in asset tracking, temperature compliance, and operational efficiency. Emanate Wireless operates on a business-to-business (B2B) model, generating revenue through product sales and potential service contracts associated with its offerings. The company engages clients such as hospitals, clinics, and pharmaceutical distributors, who may enter into subscription agreements for ongoing monitoring services or purchase individual systems outright. The firm's flagship products, including RadioVision™ and PowerPath™ Temp, are priced competitively within the industry to attract a wide range of healthcare providers looking to enhance operational protocols and ensure regulatory compliance.
Revenue streams may also arise from partnerships aimed at integrating Emanate's technology into existing healthcare infrastructures, further expanding their market reach and customer base. Emanate Wireless plans to utilize the USD 1. 5 mn raised in ANGEL financing to enhance its product development and expand its market presence. The company is designing new offerings to complement its existing solutions, with anticipated launches by late 2023.
Emanate aims to expand its operations into the European market by 2024, focusing on partnerships with healthcare institutions to facilitate technology integration and streamline services.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Analytics & Performance Software
Website
www.emanatewireless.com
Verticals
HealthTech, Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.